» Articles » PMID: 12566900

Influence of Age on the Prognosis of Patients with Renal Cell Carcinoma (RCC)

Overview
Journal Onkologie
Specialty Oncology
Date 2003 Feb 5
PMID 12566900
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Aim of this study was to analyze the prognostic value of age in patients with renal cell carcinoma (RCC).

Patients And Methods: A group of 15 patients (age < or = 40 years, group I) and a group of 103 patients (age > or = 50 years, group II) with sporadic RCC who underwent radical nephrectomy between 1985 and 1997 were compared. The two groups were analyzed with respect to histologic cell type, tumor grade, stage and outcome.

Results: In group I low-stage tumors (stage I and II) were diagnosed in 93% of patients and in group II in 65% of the patients (p = 0.017). High-grade tumors (stage III and IV) were diagnosed in 7% and 35% of patients in group I and group II, respectively (p < 0.01). In group I only one patient (7%) with stage II disease died of cancer. In group II the distribution of cancer-specific mortality was as follows: 6 patients (100%) with stage IV, 13 patients (42%) with stage III, and 12 patients (17%) with stage I and II died of disease. The 5-year-survival in group I was 93% and in group II was 77% (p = 0.05).

Conclusion: According to our data we conclude that RCC is diagnosed at a lower stage in young patients than in the older patient group. RCC may exhibit a more favorable prognosis in young patients, possible due to the lower stage at time of diagnosis.

Citing Articles

Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database.

Liao Z, Wang D, Song N, Xu Y, Ge H, Peng Z Front Oncol. 2022; 12:975779.

PMID: 36313677 PMC: 9597499. DOI: 10.3389/fonc.2022.975779.


Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.

Huang G, Liao J, Cai S, Chen Z, Qin X, Ba L Front Oncol. 2022; 12:949058.

PMID: 36237316 PMC: 9552762. DOI: 10.3389/fonc.2022.949058.


53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.

Tang F, Lu Z, He C, Zhang H, Wu W, He Z BMC Cancer. 2021; 21(1):638.

PMID: 34051738 PMC: 8164798. DOI: 10.1186/s12885-021-08376-5.


A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma.

Wu S, Li X Bioengineered. 2021; 12(1):1642-1662.

PMID: 33955826 PMC: 8806326. DOI: 10.1080/21655979.2021.1922330.


Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.

Harting M, Lally K, Andrassy R, Vaporciyan A, Cox Jr C, Hayes-Jordan A J Cancer Res Clin Oncol. 2009; 136(4):561-70.

PMID: 19784847 DOI: 10.1007/s00432-009-0690-5.